CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 43 enrolled
Drug / intervention
755nm Alex laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01745627
NCT01745627N/ACompleted
CompareCT.gov

755nm Alex Laser for Treatment of Pigmented and Vascular Lesions and Scars

Cynosure, Inc.·interventional·Posted Dec 10, 2012·Updated Dec 23, 2020

In Brief

A clinical study evaluating 755nm Alex laser for Benign Pigmented and Vascular Lesions and Scars. Completed, enrolled 43 participants across 1 site.

Detailed Summary

Evaluation of the safety and efficacy of the 755nm Alex laser for the treatment of benign pigmented and vascular lesions and scars

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBenign Pigmented and Vascular Lesions and Scars
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedDec 10, 2012
Enrollment StartOct 1, 2011
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 13.6 years ago

Interventions

755nm Alex laserdevice